Cite
MLA Citation
Giuseppe Gullo et al.. “Pilot study of bevacizumab in combination with docetaxel and cyclophosphamide as adjuvant treatment for patients with early stage HER-2 negative breast cancer, including analysis of candidate circulating markers of cardiac toxicity: ICORG 08–10 trial.” Therapeutic advances in medical oncology, vol. 11, 2019, p. . http://access.bl.uk/ark:/81055/vdc_100099956575.0x0000b7